A recent study revealed that inhibitors of receptor tyrosine kinases (RTKs) or phosphatidylinositol-3-kinase (PI3K) could improve lung function in asthma (Kim et al. 2021; Bi et al. 2020). This evidence concerns the gene NTRK1 and asthma.